{
  "question_stem": {
    "en": "A 26-year-old man is being evaluated for recurrent boils and skin abscesses. Anterior nares swab culture is performed to determine colonization by the culprit bacteria, which yields gram-positive cocci in clusters. The bacteria are able to grow in a media containing oxacillin. PCR testing reveals the pathogen has acquired the *mecA* gene. These bacteria are most likely to be resistant to which of the following antibiotics?",
    "zh": "一名26岁男性正在接受评估，因为他反复出现疖肿和皮肤脓肿。进行鼻前庭拭子培养以确定致病菌的定植情况，结果显示革兰氏阳性球菌呈簇状。该细菌能够在含有苯唑西林的培养基中生长。PCR检测显示病原体已获得*mecA*基因。这些细菌最有可能对以下哪种抗生素产生耐药性？"
  },
  "question": {
    "en": "These bacteria are most likely to be resistant to which of the following antibiotics?",
    "zh": "这些细菌最有可能对以下哪种抗生素产生耐药性？"
  },
  "options": {
    "A": {
      "en": "Cefazolin",
      "zh": "头孢唑啉"
    },
    "B": {
      "en": "Clindamycin",
      "zh": "克林霉素"
    },
    "C": {
      "en": "Doxycycline",
      "zh": "多西环素"
    },
    "D": {
      "en": "Trimethoprim-sulfamethoxazole",
      "zh": "甲氧苄啶-磺胺甲恶唑"
    },
    "E": {
      "en": "Vancomycin",
      "zh": "万古霉素"
    }
  },
  "correct_answer": "A",
  "explanation": {
    "en": "This patient with recurrent boils and skin abscesses is likely colonized with *Staphylococcus aureus*, a gram-positive cocci that grows in clusters. Methicillin-resistant strains are able to grow in the presence of oxacillin due to the acquisition of a mobile genetic element that contains the *mecA* gene, which encodes for **penicillin-binding protein (PBP) 2a**. PBPs catalyze peptidoglycan cross-linking during cell wall synthesis; they are the target of beta-lactam medications, which bind to and irreversibly destroy the enzyme. Unlike other PBPs, PBP 2a has a **low affinity for beta-lactams** and continues to cross-link peptidoglycan in the presence of oxacillin, methicillin, cephalosporins (eg, **cefazolin**), and other beta-lactam medications.\n\nTherefore, treatment of methicillin-resistant *S aureus* (MRSA) generally requires the use of a non–beta-lactam drug. Common medications for MRSA include trimethoprim-sulfamethoxazole (inhibits 2 steps in folate synthesis), clindamycin (inhibits bacterial protein synthesis by binding to the 50s ribosomal subunit), doxycycline (inhibits protein synthesis by binding to the 30s ribosomal subunit), or vancomycin (inhibits integration of peptidoglycan subunits).\n\nEducational objective: Methicillin-resistant *Staphylococcus aureus* (MRSA) is resistant to most beta-lactam medications (eg, oxacillin, methicillin, cephalosporins) due to the acquisition of a mobile genetic element that contains the *mecA* gene. This gene encodes for a specialized penicillin-binding protein that has low affinity for beta-lactam antibiotics. Treatment of MRSA therefore requires a non–beta-lactam medication such as trimethoprim-sulfamethoxazole, clindamycin, doxycycline, or vancomycin.",
    "zh": "这位反复出现疖肿和皮肤脓肿的患者可能被金黄色葡萄球菌（*Staphylococcus aureus*）定植，这是一种革兰氏阳性球菌，呈簇状生长。耐甲氧西林菌株能够在苯唑西林存在下生长，这是由于获得了包含*mecA*基因的移动遗传元件，该基因编码**青霉素结合蛋白（PBP）2a**。PBP在细胞壁合成过程中催化肽聚糖交联；它们是β-内酰胺类药物的靶标，β-内酰胺类药物与酶结合并不可逆地破坏酶。与其他PBP不同，PBP 2a对**β-内酰胺类药物的亲和力较低**，并且在苯唑西林、甲氧西林、头孢菌素（例如，**头孢唑啉**）和其他β-内酰胺类药物存在下继续交联肽聚糖。\n\n因此，耐甲氧西林金黄色葡萄球菌（MRSA）的治疗通常需要使用非β-内酰胺类药物。 MRSA的常用药物包括甲氧苄啶-磺胺甲恶唑（抑制叶酸合成中的2个步骤）、克林霉素（通过与50s核糖体亚基结合抑制细菌蛋白质合成）、多西环素（通过与30s核糖体亚基结合抑制蛋白质合成）或万古霉素（抑制肽聚糖亚基的整合）。\n\n教育目标：耐甲氧西林金黄色葡萄球菌（MRSA）对大多数β-内酰胺类药物（例如，苯唑西林、甲氧西林、头孢菌素）具有耐药性，这是由于获得了包含*mecA*基因的移动遗传元件。该基因编码一种对β-内酰胺类抗生素亲和力较低的特殊青霉素结合蛋白。因此，MRSA的治疗需要非β-内酰胺类药物，例如甲氧苄啶-磺胺甲恶唑、克林霉素、多西环素或万古霉素。"
  },
  "summary": {
    "en": "This question tests knowledge of methicillin-resistant Staphylococcus aureus (MRSA) and its resistance mechanisms to beta-lactam antibiotics. It assesses understanding of the mecA gene and its role in encoding a penicillin-binding protein with low affinity for beta-lactams.\n\nThe key to solving this question is recognizing that the mecA gene confers resistance to beta-lactam antibiotics like cefazolin. Therefore, the correct answer will be a beta-lactam antibiotic, while other options are typically used to treat MRSA infections.",
    "zh": "这个问题考察了对耐甲氧西林金黄色葡萄球菌（MRSA）及其对β-内酰胺类抗生素的耐药机制的了解。它评估了对*mecA*基因的理解及其在编码对β-内酰胺类药物亲和力较低的青霉素结合蛋白中的作用。\n\n解决这个问题的关键是认识到*mecA*基因赋予了对β-内酰胺类抗生素（如头孢唑啉）的耐药性。因此，正确答案将是一种β-内酰胺类抗生素，而其他选项通常用于治疗MRSA感染。"
  },
  "tags": "Methicillin-resistant Staphylococcus aureus (MRSA); mecA gene; Beta-lactam resistance; Antibiotic resistance; Infectious diseases; Staphylococcus aureus; Cefazolin; Penicillin-binding protein; Antimicrobial resistance",
  "category": "Micro",
  "question_id": "15347",
  "has_exhibits": false,
  "exhibit_count": 0,
  "exhibit_files": [],
  "folder_path": "C:\\Datas\\usmle\\step1\\clip\\Micro 23\\15347",
  "extracted_at": "2025-11-05T14:59:03.863492",
  "extraction_config": {
    "temperature": 0.1,
    "top_k": 1,
    "prompt_strategy": "standard"
  },
  "translated_at": "2025-11-07T18:08:35.919645",
  "translation_model": "gemini-2.0-flash-lite",
  "embedding_model": "models/embedding-001",
  "embedding_dimension": 768
}